CEO Lars Fruergaard Jorgensen discusses Wegovy
They have been a few rocky months to Novo Nordisk. IQVIA prescription data suggest that the Novo Wegovy Obesity Medication…
business news
Teladoc Health to acquire Catapult Health in a $ 65 million agreement
Pavlo Gonchanche | LIGHTROCKET | Getty images Teradoc health The shares rose 6% on Wednesday after the company announced that…
Trump sued for the surveys of January 6, the elimination of clinical data of the FDA
The Trump administration was sued on Tuesday in two separated civil complaints related to a request for information on FBI…
Merck profits (MRK) Q4 2024
Soup images | LIGHTROCKET | Getty images Merck On Tuesday, he issued an income guide of 2025 per full year…
Trump's tariffs could increase drug costs, worsen scarcity
Shana Novak | Stone | Getty images President Donald Trump's pronounced tariffs on Canada, Mexico and China could worsen the…
The new Honda EV Production Revolution begins with $ 1 billion in Ohio
A Honda sedan moves along the assembly line on January 28, 2025 at the car manufacturer's assembly plant in Marysville,…
Reid Hoffman launches Manas AI, a new drug discovery startup
Reid Hoffman, Greylock partner and LinkedIn co -founder, speaks during the WSJ Tech Live conference organized by the Wall Street…
Trump's tariffs on Mexico and Canada challenge the automotive industry
A car transport trailer waits in the row next to the border wall before crossing the United States in the…
We are lightening in a stock of rally that has become too big in our portfolio
The sale also occurs when our trusted impulse indicator moved more to the overcompra territory.
Novo Nordisk Ozempic wins FDA approval for chronic kidney disease
Food and medication administration approved Tuesday Novo Nordisk'S Ozempic to treat chronic kidney disease in patients who also have type…